fashion -WSS

fashion

author：explore 2025-09-27 16:50:19 - browse：39

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Adam's Biotech Scorecard: Do Sarepta's exon

WSS

Stigma and the return of syphilis

Focused ultrasound for uterine fibroids: an uphill battle

Latest bird flu infection made farmworker sicker than earlier cases

Health insurers say they are turning to AI to cut costs, improve care

What will save rural psychiatry services? Higher Medicaid payments

Tori Bowie and the unacceptable rates of Black maternal death

explore

fashion

focus

As demand for Covid shots wanes, Moderna seeks its next success

As demand for Covid shots wanes, Moderna seeks its next success

Trump demands the U.S. pay no more for drugs than other countries … again

The cancer drug shortage isn’t new — and neither are the solutions

Wildfire smoke exposes gaps in outdoor worker protections

23andMe had bad news about my health. I wish a person had delivered it

After affirmative action ruling, medical educators look to 'holistic review'

Latest bird flu infection made farmworker sicker than earlier cases

New air purifier tech could be key to improving indoor air quality

Childbirth

focus

23andMe had bad news about my health. I wish a person had delivered it

Startling documents reveal new facets of Sacklers' opioid empire

Focused ultrasound for uterine fibroids: an uphill battle

Medical records are filled with copy

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Akili, maker of video game for ADHD, to be acquired for 34 million

entertainment

hotspot

entertainment

leisure time